Jichan Shi

1.1k total citations
24 papers, 443 citations indexed

About

Jichan Shi is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Jichan Shi has authored 24 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 14 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Jichan Shi's work include Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (9 papers) and COVID-19 Clinical Research Studies (7 papers). Jichan Shi is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Mycobacterium research and diagnosis (9 papers) and COVID-19 Clinical Research Studies (7 papers). Jichan Shi collaborates with scholars based in China and United States. Jichan Shi's co-authors include Xiangao Jiang, Guiqing He, Zhengxing Wu, Jianyi Dai, Jianping Huang, Tianxiao Zhang, Megan Coffee, Anasse Bari, Yitong Huang and Jing Cai and has published in prestigious journals such as Chemical Engineering Journal, BMC Medicine and Frontiers in Pharmacology.

In The Last Decade

Jichan Shi

20 papers receiving 419 citations

Peers

Countries citing papers authored by Jichan Shi

Since Specialization

Citations

This map shows the geographic impact of Jichan Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jichan Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jichan Shi more than expected).

Fields of papers citing papers by Jichan Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jichan Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jichan Shi. The network helps show where Jichan Shi may publish in the future.

Co-authorship network of co-authors of Jichan Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Jichan Shi. A scholar is included among the top collaborators of Jichan Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jichan Shi. Jichan Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China 2025 ·BMC Infectious Diseases ·(unknown), Xiaoqing Lin, Qiang Zhang, (unknown), (unknown), Mingying Zhang, (unknown), (unknown), Cheng Fang, (unknown), Jichan Shi, Xiangao Jiang	0
2	Clinical Efficacy of Continuous Renal Replacement Therapy in Patients with Pulmonary Tuberculosis Complicated with Sepsis: A Retrospective Observational Study 2025 ·Infection and Drug Resistance ·Xin Chen, Xiaoqing Lin, Cheng Fang, Shilin Zheng, Qiang Zhang, (unknown), Jichan Shi	1
3	Diagnostic value of GeneXpert MTB/RIF in bronchoalveolar lavage fluid for pulmonary non-tuberculosis mycobacterial in acid-fast stain smear-positive and GeneXpert MTB/RIF-negative cases 2025 ·Journal of Thoracic Disease ·Zhengxing Wu, Jichan Shi, (unknown), (unknown), (unknown), Lianpeng Wu, Xiangao Jiang	0
4	Study on the clinical efficacy and safety of baloxavir marboxil tablets in the treatment of influenza A 2024 ·Frontiers in Medicine ·(unknown), Fang Cheng, Xinchun Ye, Zhengxing Wu, (unknown), (unknown), Lianpeng Wu, Yiyang Zhang, Jichan Shi, Xiangao Jiang	1
5	ACURAT: Advancing tuberculosis detection through assembled PCR & CRISPR for ultra-sensitive Rifampin-resistant analysis testing 2024 ·Chemical Engineering Journal ·(unknown), Lexiang Zhang, (unknown), Rokshana Parvin, (unknown), Dan Yao, (unknown), Jichan Shi, Fangyou Yu, Zhongyong Wang, (unknown), Lianpeng Wu, Keqing Shi, Fangfu Ye, Xiaoying Huang	4
6	Efficacy and safety of Nirmatrelvir/Ritonavir for treating the Omicron variant of COVID-19 2023 ·Frontiers in Medicine ·(unknown), Zhengxing Wu, Xiaojing Liu, Qiang Zhang, Lianpeng Wu, Xinchun Ye, (unknown), Jichan Shi, Xiangao Jiang	2
7	Strain Identification and Drug Resistance Analysis of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry in Nontuberculous Mycobacterial Lung Disease 2023 ·Infection and Drug Resistance ·Jichan Shi, (unknown), (unknown), Lianpeng Wu, (unknown), (unknown), Xinchun Ye, Xiangao Jiang	3
8	N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study 2023 ·Frontiers in Pharmacology ·Fang Cheng, Xiangao Jiang, (unknown), (unknown), Qiang Zhang, Xinchun Ye, (unknown), Jichan Shi	4
9	Incidence, causes, and risk factors for unplanned readmission in patients admitted with pulmonary tuberculosis in China 2023 ·The Journal of Infection in Developing Countries ·Xinchun Ye, (unknown), Jichan Shi, Xiangao Jiang, (unknown), Fang Cheng, (unknown), (unknown), Chen‐Wei Pan	2
10	Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients 2022 ·Tuberculosis ·Jichan Shi, Guiqing He, (unknown), Lianpeng Wu, (unknown), Xinchun Ye, (unknown), Xiangao Jiang	17
11	The Diagnostic Value of the Thermostatic Amplification of Ribonucleic Acid in Bronchoalveolar Lavage Fluid in Smear-Negative Pulmonary Tuberculosis 2022 ·Frontiers in Public Health ·Zhengxing Wu, Jichan Shi, (unknown), (unknown), (unknown), Lianpeng Wu, Xiangao Jiang	5
12	The diagnosis of leptospirosis complicated by pulmonary tuberculosis complemented by metagenomic next-generation sequencing: A case report 2022 ·Frontiers in Cellular and Infection Microbiology ·Jichan Shi, Wenjie Wu, Kang Wu, (unknown), Guiqing He, Shilin Zheng, Cheng Fang, (unknown), Ruotong Ren, Xiangao Jiang	4
13	Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of Mycobacterium tuberculosis Infections in Immunocompromised Patients: a Real-World Study 2022 ·Microbiology Spectrum ·Yuzhen Xu, (unknown), Jingyu Zhou, (unknown), (unknown), Yan Gao, Lingyun Shao, Jichan Shi, Qiaoling Ruan, Wenhong Zhang	12
14	Clinical Characteristics of Patients With Re-admitted of Novel Coronavirus 2019 (nCOVID-19) in Wenzhou, China 2021 ·Frontiers in Public Health ·Xinchun Ye, (unknown), Risheng Huang, (unknown), Zhijie Yu, Ziyang Huang, Rongrong Chen, Xiangao Jiang, (unknown), Jichan Shi	2
15	Correlation Analysis Between Serum Uric Acid, Prealbumin Level, Lactate Dehydrogenase, and Severity of COVID-19 2021 ·Frontiers in Molecular Biosciences ·(unknown), (unknown), Jichan Shi, Xinchun Ye, Fang Cheng, (unknown), Jianping Huang, Xiangao Jiang	8
16	Increased levels of lactate dehydrogenase and hypertension are associated with severe illness of COVID-19 2021 ·World Journal of Clinical Cases ·(unknown), Jichan Shi, (unknown), (unknown), (unknown), Fang Cheng, Jing Cai, Xiangao Jiang	2
17	Imaging features of COVID-19: A series of 56 cases 2020 ·Jichan Shi, Xiangao Jiang, (unknown), Xinchun Ye, (unknown), Zhengxing Wu, Yi Lü, (unknown), (unknown)	1
18	Analysis of clinical features of 42 cases of new coronavirus pneumonia 2020 ·(unknown), Xiangao Jiang, (unknown), Xinchun Ye, Ning Pan, (unknown), Yueying Zhou, (unknown), Jichan Shi	0
19	Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study 2020 ·BMC Medicine ·Jichan Shi, Yang Li, Xian Zhou, Qiran Zhang, Xinchun Ye, Zhengxing Wu, Xiangao Jiang, Hongying Yu, Lingyun Shao, (unknown), H. C. Zhang, Bin Xu, Feng Sun, Wenhong Zhang	59
20	ZNRF3 contributes to the growth of lung carcinoma via inhibiting Wnt/β-catenin pathway and is regulated by miR-93 2015 ·Tumor Biology ·Jichan Shi, Xiangao Jiang, Zhijie Yu, Guiqing He, (unknown), Zhengxing Wu, (unknown), (unknown), (unknown)	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact